What Is Qiagen N.V. (QGEN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Qiagen N.V. presents a highly debated valuation profile at its current price of $43.11. The median intrinsic value is estimated at $48.24 (+11.9% median upside), masking a wide model spread between the 1 bullish models and 1 bearish models. Model dispersion is worth noting: Regime Cross targets $80.61 (+87.0%), versus Markov DDM at $15.87 (-63.2%). This +150.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About QGEN?
2 of 13 models are currently active for QGEN. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for QGEN is $48.24 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →
How Does QGEN Rank in Diagnostics & Research?
Among 52 Diagnostics & Research stocks, QGEN ranks #49 by Quality of Company score. CirclFi's QOC score of 3.2/10 evaluates 32 fundamental signals. A score of 3.2 signals below-average fundamentals.
As a biopharma enterprise, Qiagen N.V. operates in a sector where FDA approval probability is a critical driver of valuation. Investors evaluating QGEN should weigh these sector-specific dynamics alongside our model-derived fair values.
Is QGEN a Value Trap?
CirclFi's Value Trap algorithm assigns QGEN a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
2 of 13 models are active for Qiagen N.V.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Qiagen N.V.'s fundamental quality profile registers 3.2/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +150.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every QGEN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across QGEN's 2 active models, average confidence is 29%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad